Electron Transport Chain and Oxidative Phosphorylation

🟢 Lite — Quick Review (1h–1d)

Rapid summary for last-minute revision before your exam.

The Electron Transport Chain (ETC) is the final common pathway for extracting energy from food — it transfers electrons from NADH and FADH₂ to oxygen, using the energy released to pump protons and synthesize ATP. INI CET frequently asks about the four complexes, inhibitors, ATP yield, and the chemiosmotic mechanism.

High-Yield Facts for INI CET:

• 4 complexes: Complex I (NADH dehydrogenase), II (succinate dehydrogenase), III (cytochrome bc1), IV (cytochrome oxidase)
• CoQ (ubiquinone) and cytochrome c are mobile electron carriers
• NADH → ~2.5 ATP; FADH₂ → ~1.5 ATP (FADH₂ enters at Complex II, bypasses Complex I)
• ATP synthase (Complex V): F₀ (membrane channel) + F₁ (catalytic head) — protons flow through F₀ → drive F₁ to make ATP
• Poison inhibitors: Cyanide (Complex IV), CO (Complex IV), oligomycin (ATP synthase), DNP (uncoupler)

⚡ Exam tip: FADH₂ enters the chain at Complex II (succinate dehydrogenase), so it bypasses Complex I and yields fewer ATP. This is why the TCA cycle’s succinate dehydrogenase step yields only 1.5 ATP equivalent, while the three NADH-producing steps yield 2.5 each.

---

🟡 Standard — Regular Study (2d–2mo)

Standard content for students with a few days to months.

Electron Transport Chain and Oxidative Phosphorylation — INI CET (AIIMS PG) Study Guide

Overview of the ETC

Location: Inner mitochondrial membrane (cristae) — the highly folded membrane increases surface area Function: Transfer electrons from NADH and FADH₂ to oxygen, using the released energy to synthesize ATP

The Electron Carriers:

1. Complex I (NADH:ubiquinone oxidoreductase):

   • Receives electrons from matrix NADH → transfers to CoQ
   • FMN (flavin mononucleotide) is the first electron acceptor
   • Contains iron-sulfur (Fe-S) clusters as electron carriers
   • Pumps 4 H⁺ from matrix to intermembrane space per NADH
   • NADH → CoQ is the rate-limiting step of the ETC

2. Coenzyme Q (Ubiquinone, CoQ10):

   • Mobile, lipid-soluble carrier in the membrane
   • Accepts 1 or 2 electrons → becomes semi-ubiquinone (one e⁻) or ubiquinol (two e⁻, reduced form)
   • Carries electrons from Complex I and Complex II to Complex III
   • Recycles between oxidized (CoQ) and reduced (CoQH₂) states

3. Complex II (Succinate dehydrogenase):

   • Same enzyme that acts in TCA cycle (unique among ETC complexes)
   • FADH₂ produced here donates electrons directly to CoQ (bypassing Complex I)
   • Does NOT pump protons (no H⁺ translocation)
   • Yields ~1.5 ATP per FADH₂

4. Complex III (Cytochrome bc₁ complex / Q-cytochrome c oxidoreductase):

   • Q cycle transfers electrons from reduced CoQH₂ to cytochrome c
   • Cytochrome c is the mobile carrier here (carries one electron at a time)
   • Pumps 4 H⁺ per Q cycle (per pair of electrons)
   • Contains two cytochrome b hemes (bₗ and bₕ), one Rieske Fe-S protein, cytochrome c₁

5. Cytochrome c:

   • Mobile peripheral membrane protein
   • Carries one electron at a time from Complex III to Complex IV
   • Contains heme iron (alternates between Fe³⁺ and Fe²⁺)

6. Complex IV (Cytochrome c oxidase):

   • Final enzyme in the chain — transfers electrons from cytochrome c to O₂
   • O₂ + 4e⁻ + 4H⁺ → 2H₂O (is the terminal electron acceptor)
   • Uses two hemes (a and a₃) and copper A and B centers
   • Pumps 2 H⁺ per pair of electrons
   • Inhibited by cyanide (binds Fe³⁺ of cytochrome a₃), CO (binds Fe²⁺ of cytochrome a₃)

Oxidative Phosphorylation — The Chemiosmotic Theory

Chemiosmotic Coupling (Peter Mitchell, 1978 Nobel Prize):

1. ETC transfers electrons → energy released → complexes I, III, IV pump H⁺ from matrix to intermembrane space
2. This creates an electrochemical proton gradient (proton motive force):
   • Δψ (electrical potential): More positive outside than inside
   • ΔpH (concentration difference): Intermembrane space has lower pH (more H⁺) than matrix
3. Protons flow back through ATP synthase (Complex V) — from intermembrane space to matrix
4. The energy from this proton flow drives the synthesis of ATP from ADP + Pi

ATP Synthase (F₀F₁ ATPase):

• F₀ (membrane-embedded): Forms the proton channel; has the proton-binding sites
• F₁ (matrix-facing): Contains the catalytic sites for ATP synthesis
• Propose rotation: As H⁺ flow through F₀, they cause the rotor to spin → conformational changes in F₁催化 ADP + Pi → ATP
• Oligomycin (antibiotic) binds F₀ and blocks the proton channel → ATP synthesis stops, but ETC continues and runs without making ATP

Proton Gradient Across the Inner Mitochondrial Membrane:

• Intermembrane space: ~10,000× more concentrated in H⁺ than matrix (creates ~180 mV potential)
• Total proton motive force = Δψ + (2.3 × RT/F) × log([H⁺]out/[H⁺]in) = ~220 mV
• Requires ~3 H⁺ to synthesize 1 ATP (from ADP + Pi)

Energy Yield Calculation

ATP from Complete Glucose Oxidation:

Stage	NADH	FADH₂	ATP (direct)	Total ATP
Glycolysis	2 NADH (cytosol)	0	2	~6-8*
Pyruvate dehydrogenase	2 NADH (matrix)	0	0	5
TCA cycle	6 NADH	2 FADH₂	2 GTP	20
Total	10 NADH	2 FADH₂	4	~30-32

*Note: Cytosolic NADH must be shuttled into mitochondria. Glycerol-phosphate shuttle yields ~1.5 ATP per NADH; malate-aspartate shuttle yields ~2.5 ATP per NADH.

Inhibitors of the ETC

Inhibitor	Target	Effect
Rotenone	Complex I	Blocks NADH → CoQ; Parkinson’s-like model (complex I defects in Parkinson’s)
Barbiturates (amytal)	Complex I	Same as rotenone
Antimycin A	Complex III	Blocks Q cycle (cytochrome bc₁); prevents electron transfer from cytochrome b to Q
Cyanide (CN⁻)	Complex IV	Binds Fe³⁺ of cytochrome a₃ → blocks O₂ reduction → immediate death
Carbon monoxide (CO)	Complex IV	Binds Fe²⁺ of cytochrome a₃ → same mechanism as cyanide
Oligomycin	ATP synthase (F₀)	Blocks proton flow through F₀ → no ATP synthesis → ETC runs but without energy capture
DNP, FCCP, CCCP	Membrane (uncouplers)	Dissipate H⁺ gradient → ETC runs at max speed, no ATP synthesis → hyperthermia

Uncouplers and Thermogenesis:

• Uncouplers destroy the gradient — ETC runs at maximum speed (no back-pressure from H⁺ accumulation)
• All energy released as heat instead of ATP
• DNP used historically as weight-loss drug (dangerous — causes hyperthermia, death)
• Brown adipose tissue has UCP1 (uncoupling protein 1) for non-shivering thermogenesis — controlled by sympathetic nervous system via norepinephrine

---

🔴 Extended — Deep Study (3mo+)

Comprehensive coverage for students on a longer study timeline.

Mitochondrial Structure and Organization

Inner mitochondrial membrane:

• Highly impermeable (except through specific transporters)
• Contains the ETC complexes and ATP synthase
• Cristae increase surface area for ETC (cristae are the folds)

Intermembrane space:

• Contains H⁺ gradient (higher [H⁺], lower pH than matrix)
• Limited space — gradient builds up rapidly

Matrix:

• Contains TCA cycle, β-oxidation, pyruvate dehydrogenase
• Has lower [H⁺] (more alkaline) than intermembrane space
• pH difference is ~0.5-1 unit (intermembrane pH ~7.0, matrix pH ~7.8-8.0)

Transporters:

• ADP/ATP translocase (ANT): Exchanges matrix ADP for cytosolic ATP (antiport); critical for ATP export
• Pi carrier: Imports inorganic phosphate (Pi) from cytosol into matrix
• Pyruvate carrier: Imports pyruvate from cytosol into matrix
• Citrate carrier: Exports citrate from matrix to cytosol (for fatty acid synthesis)
• Malate-α-ketoglutarate carrier: Used in malate-aspartate NADH shuttle

The Malate-Aspartate Shuttle (NADH Shuttle)

Problem: Cytosolic NADH cannot cross the inner mitochondrial membrane directly Solution: Malate-aspartate shuttle transfers reducing equivalents (as NADH) into matrix

Steps:

1. Cytosolic NADH reduces oxaloacetate → malate (malate dehydrogenase, NADH-dependent)
2. Malate enters matrix via malate-α-KG carrier
3. Matrix malate → oxaloacetate + NADH (matrix malate dehydrogenase)
4. OAA + glutamate → aspartate + α-ketoglutarate (aspartate aminotransferase)
5. Aspartate exits via carrier; α-KG exits via same carrier
6. Cytosolic aspartate + α-KG → OAA + glutamate (regenerates OAA to continue cycle)
7. Net: Cytosolic NADH → Matrix NADH (yields 2.5 ATP per NADH)

Glycerol-Phosphate Shuttle (alternative):

• Cytosolic NADH reduces DHAP → glycerol-3-phosphate (via glycerol-3-phosphate dehydrogenase)
• Glycerol-3-P enters mitochondria; reoxidized by FAD-dependent glycerol-3-P dehydrogenase (bound to outer surface of inner membrane)
• Yields only 1.5 ATP per NADH (because electrons enter at FADH₂ level)
• This shuttle predominates in skeletal muscle and brain

Reactive Oxygen Species and Antioxidant Defense

ROS production in ETC:

• Electron leakage occurs at Complex I (NADH) and Complex III (Q cycle)
• Partially reduced O₂ species form: superoxide (O₂⁻·), hydrogen peroxide (H₂O₂), hydroxyl radical (·OH)
• ~0.2-2% of O₂ consumed → partially reduced (not pathological under normal conditions)

Sources of ROS:

• Complex I: NADH dehydrogenase (Flavoprotein) produces superoxide
• Complex III: Q cycle (semi-ubiquinone autoxidation) produces superoxide
• Matrix: Mn-SOD converts O₂⁻· → H₂O₂ → H₂O by catalase or GPx

Antioxidant defenses:

• SOD (superoxide dismutase): Mn-SOD (matrix), Cu/Zn-SOD (cytosol and intermembrane space)
• Catalase: Converts H₂O₂ → 2H₂O (in peroxisomes)
• Glutathione peroxidase (GPx): Uses reduced glutathione (GSH) to reduce H₂O₂ → H₂O; GSH → GSSG; regenerated by glutathione reductase (requires NADPH)
• Vitamin E (α-tocopherol): Lipid-soluble antioxidant in membranes
• Vitamin C: Aqueous phase antioxidant; can regenerate vitamin E

Disease relevance:

• Chronic ROS production → oxidative stress → lipid peroxidation, protein oxidation, DNA damage
• Neurodegenerative diseases (Alzheimer’s, Parkinson’s): mitochondrial dysfunction and ROS implicated
• Aging: mitochondrial DNA (mtDNA) accumulates mutations (no histones, limited repair) → cumulative ETC dysfunction

Mitochondrial Myopathies and ETC Disorders

Leigh Syndrome (subacute necrotizing encephalomyelopathy):

• Mitochondrial disorder; presents in infancy with developmental regression, ataxia, dystonia, respiratory abnormalities
• Caused by: Pyruvate dehydrogenase deficiency, Complex I deficiency (most common), Complex IV deficiency
• MRI: Bilateral symmetric lesions in basal ganglia, brainstem

MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, Stroke-like episodes):

• Caused by mtDNA mutation (most commonly A3243G in tRNA Leu gene)
• Stroke-like episodes, lactic acidosis, ragged red fibers on muscle biopsy ( Gomori trichrome stain shows subsarcolemmal mitochondrial accumulation)
• Heteroplasmy: Different proportions of mutant vs wild-type mtDNA in different tissues → variable expression

Kearns-Sayre Syndrome (KSS):

• mtDNA deletion; presents before age 20
• Triad: Progressive external ophthalmoplegia, pigmentary retinopathy, cardiac conduction defects
• Plus: CSF protein elevation, cerebellar ataxia, sensorineural hearing loss

Complex I (NADH dehydrogenase) deficiency:

• Most common respiratory chain defect
• Causes: Leigh syndrome, MELAS, cardiomyopathy
• Mutations in 7 of 45 subunits encoded by mtDNA; rest nuclear-encoded

Clinical Pharmacology — ETC as Drug Target

Metformin:

• Biguanide; used in type 2 diabetes
• Inhibits Complex I (NADH dehydrogenase) → reduces hepatic ATP → increases AMP/ATP ratio → activates AMPK → reduces gluconeogenesis
• Also reduces mitochondrial ROS production (protective effect)

Barbiturates:

• Bind and inhibit Complex I (like rotenone)
• Used in anesthesia and for barbiturate coma in elevated intracranial pressure

Mitochondrial toxins as chemical warfare:

• Cyanide (CN⁻): Inhibits Complex IV → rapid death (cellular respiration stops)
• Sarin: Inhibits acetylcholinesterase (not ETC, but causes respiratory failure)
• DNP: Uncoupler → hyperthermia and death

Anticancer drug — arsenic trioxide:

• Used in acute promyelocytic leukemia (APL)
• Causes mitochondrial dysfunction, ROS generation, apoptosis

⚡ INI CET High-Yield: Remember that Complex I, III, and IV pump protons; Complex II does not. FADH₂ from succinate dehydrogenase enters at CoQ (bypasses Complex I) → yields only 1.5 ATP vs 2.5 for NADH. The chemiosmotic theory is key: gradient energy → ATP synthesis. Cyanide inhibits cytochrome oxidase (Complex IV); oligomycin inhibits ATP synthase. DNP uncouples the chain (makes ATP synthesis impossible, heat generated — dangerous drug).

---

Content adapted based on your selected roadmap duration. Switch tiers using the selector above.